Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia

PHASE3CompletedINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Leukemia
Interventions
DRUG

cytarabine

Given IV

DRUG

laromustine

Given IV

OTHER

placebo

Given IV

Trial Locations (62)

1200

Cliniques Universitaires Saint-Luc, Brussels

6110

CHU Charleroi - Site Vesale, Montigny-le-Tilleul

10595

New York Medical College, Valhalla

10676

Evaggelismos Hospital, Athens

11000

Clinical Centre of Serbia, Belgrade

13273

Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes, Marseille

15224

Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital, Pittsburgh

18000

Clinical Centre Nis, Niš

21000

Clinic Centre Novi Sad, Novi Sad

21201

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore

25030

Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz, Besançon

27710

Duke Comprehensive Cancer Center, Durham

27858

Brody School of Medicine at East Carolina University, Greenville

29425

Hollings Cancer Center at Medical University of South Carolina, Charleston

33136

University of Miami Sylvester Comprehensive Cancer Center, Miami

33604

Hopital Haut Leveque, Pessac

33612

Veterans Affairs Medical Center - Tampa (Haley), Tampa

44093

CHR Hotel Dieu, Nantes

46260

American Health Network - North Meridian, Indianapolis

69437

Hopital Edouard Herriot, Lyon

87106

New Mexico Cancer Care Alliance, Albuquerque

89135

Nevada Cancer Institute, Las Vegas

92868

Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Orange

94115

UCSF Comprehensive Cancer Center, San Francisco

90089-9181

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

06105

Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, Hartford

60611-3013

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

60637-1470

University of Chicago Cancer Research Center, Chicago

02115

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

14263-0001

Roswell Park Cancer Institute, Buffalo

43214-3998

Riverside Methodist Hospital Cancer Care, Columbus

17033-0850

Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey

37232-6838

Vanderbilt-Ingram Cancer Center, Nashville

77030-4009

M.D. Anderson Cancer Center at University of Texas, Houston

B-3000

U.Z. Gasthuisberg, Leuven

V5Z 4E3

Vancouver Hospital and Health Science Center, Vancouver

E2L 4L2

Saint John Regional Hospital, Saint John

A1B 3V6

Memorial University of Newfoundland, St. John's

B3H 1V7

Capital District Health Authority Center for Clinical Research, Halifax

K1H 8L6

Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa

M5G 2M9

Princess Margaret Hospital, Toronto

D-12200

Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin

D-50924

Medizinische Universitaetsklinik I at the University of Cologne, Cologne

D-60596

Universitaetsfrauenklinik Frankfurt, Frankfurt

D-69115

Universitatsklinikum Heidelberg, Heidelberg

D-81377

Klinikum der Universitaet Muenchen - Grosshadern Campus, Munich

D-48149

Medizinische Klinik und Poliklinik A - Universitaetsklinikum Muenster, Münster

D-97070

University Wurzburg, Würzburg

GR-26500

University of Patras Medical School, Rio Patras

9713 GZ

University Medical Center Groningen, Groningen

80-211

Medical University of Gdansk, Gdansk

90-419

Medical University of Lodz, Lodz

20-954

Centrum Onkologii Ziemi Lubelskiez, Lublin

00-909

Wojskowy Instytut Medyczny, Warsaw

00-957

Institute of Haematology and Blood Transfusion, Warsaw

B9 5SS

Birmingham Heartlands Hospital, Birmingham

CB2 2QQ

Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust, Cambridge

LE1 5WW

Leicester Royal Infirmary, Leicester

SE5 9RS

King's College Hospital, London

M13 9WL

Manchester Royal Infirmary, Manchester

CF14 4XW

University Hospital of Wales, Cardiff

Sponsors
All Listed Sponsors
lead

Vion Pharmaceuticals

INDUSTRY

NCT00112554 - Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter